196 related articles for article (PubMed ID: 12170442)
1. Adjuvant therapy for patients with high-risk malignant melanoma.
McClay EF
Semin Oncol; 2002 Aug; 29(4):389-99. PubMed ID: 12170442
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapy for cutaneous melanoma.
Treisman J; Garlie N
Clin Plast Surg; 2010 Jan; 37(1):127-46. PubMed ID: 19914464
[TBL] [Abstract][Full Text] [Related]
4. The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients.
Eggermont AMM; Dummer R
Eur J Cancer; 2017 Nov; 86():101-105. PubMed ID: 28968566
[TBL] [Abstract][Full Text] [Related]
5. What's new in the treatment of cutaneous melanoma?
Olhoffer IH; Bolognia JL
Semin Cutan Med Surg; 1998 Jun; 17(2):96-107. PubMed ID: 9669603
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy of melanoma.
Spitler LE
Oncology (Williston Park); 2002 Jan; 16(1 Suppl 1):40-8. PubMed ID: 11829281
[TBL] [Abstract][Full Text] [Related]
7. Update on the systemic treatment of malignant melanoma.
Lawson DH
Semin Oncol; 2004 Apr; 31(2 Suppl 4):33-7. PubMed ID: 15124132
[TBL] [Abstract][Full Text] [Related]
8. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract][Full Text] [Related]
9. European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma.
Eggermont AM; Gore M
Semin Oncol; 2002 Aug; 29(4):382-8. PubMed ID: 12170441
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy for high-risk primary and resected metastatic melanoma.
Hersey P
Intern Med J; 2003; 33(1-2):33-43. PubMed ID: 12534876
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary treatment of primary melanoma.
Yao K; Balch G; Winchester DJ
Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant application of interferons.
el Kassas H; Kirkwood JM
Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
[No Abstract] [Full Text] [Related]
14. (Neo)adjuvant systemic therapy for melanoma.
van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy of melanomas].
Zimmer L; Vaubel J; Schadendorf D
Hautarzt; 2012 Dec; 63(12):952-8. PubMed ID: 23097082
[TBL] [Abstract][Full Text] [Related]
16. The adjuvant treatment of malignant melanoma.
Reintgen D; Kirkwood J
J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the care of the patient with malignant melanoma.
Reintgen D; Balch CM; Kirkwood J; Ross M
Ann Surg; 1997 Jan; 225(1):1-14. PubMed ID: 8998115
[TBL] [Abstract][Full Text] [Related]
18. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
19. Case of malignant melanoma that developed the ability to secrete granulocyte colony-stimulating factor.
Nakamura Y; Ishikawa K; Kai Y; Shimada H; Kawano M; Iwasaki T; Tagomori H; Tanata K; Tsumura H; Arakane M; Nishida H; Yokoyama S; Hatano Y; Fujiwara S
J Dermatol; 2016 May; 43(5):580-2. PubMed ID: 26777544
[No Abstract] [Full Text] [Related]
20. Current and planned multicenter trials for patients with primary or metastatic melanoma.
Sondak VK; Han D; Deneve J; Kudchadkar R
J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]